Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable pharmaceutical-grade cannabis products/services that are produced, delivered and consumed utilizing fewer natural resources. Blue Diamond Ventures Inc. seeks opportunities in medical cannabis markets and is driven bycritical thinking and the scientific method.
2.3 There isNO dilution other than the restricted shares that were issued as part of the 25% share exchange agreement with Cann10 North America in December 2017 – link back in share structure monitoring post history below:
iii) Production: Cann10 is interested in taking an equity position in production facilities worldwide. We bring extensive experience, a well developed building, outfitting and preparation program together with the expertise to cut the time needed to turn an empty space into a revenue generating facility. We do not provide this as a service, but will provide the necessary know-how, plants, technologies and techniques to farms in which we are partners. We are currently involved in new projects in Canada, Portugal, Australia and other locations.
5.5 Cannareet and Israeli technologies: Certified by Israel Ministry of Health GAP and GMP as well as other local authorities. Developed in cann10’s own labs, Cannareet products are ideal for dispensaries and for retail use where allowed by law. Cannareet will feature oils, vapes, flowers, cigarettes and caplets available. Special orders can be prepared based on a minimum quantity.
6.5 Virginia – Cannareet and CannX 10/22/18 PR - Key Extract:
The final decision for the five cannabis oil processing licenses in Virginia was announced on September 25, 2108, and the winning company in Southwestern Virginia was Dharma Pharmaceuticals based in Bristol, Virginia. Dharma will secure, from Cann10, the exclusive license for the Commonwealth of Virginia to produce the newest targeted cannabis oil formulations from Cann10.
“This contract validates the go to market strategy that we have been developing with our North America partners” said Yossi Bornstein CEO of Cann10 & Cann10 North America “The technologies coming from the Cann10 XL, our cannabis accelerator in Israel, can give operators a competitive sustainable advantage in the US and Canada.”
This month at the CannX Conference in Israel October 14-16, BLDV took center stage by securing first GMP Certified product line to enter into the USA as a major accomplishment by Cann10 North America and Blue Diamond Ventures Inc.
News 
Market Data 
Discover 
